Fourpath Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-648
Closed -$126K 291
2024
Q3
$126K Sell
648
-281
-30% -$58.8K 0.02% 259
2024
Q2
$215K Sell
929
-106
-10% -$23K 0.16% 122
2024
Q1
$223K Sell
1,035
-53
-5% -$12.4K 0.15% 128
2023
Q4
$282K Sell
1,088
-15
-1% -$3.68K 0.19% 97
2023
Q3
$283K Sell
1,103
-29
-3% -$7.76K 0.21% 94
2023
Q2
$322K Sell
1,132
-20
-2% -$5.95K 0.39% 70
2023
Q1
$320K Buy
1,152
+1
+0.1% +$277 0.22% 97
2022
Q4
$319K Sell
1,151
-221
-16% -$62.4K 0.23% 90
2022
Q3
$366K Sell
1,372
-272
-17% -$57.8K 0.25% 80
2022
Q2
$335K Sell
1,644
-288
-15% -$58.9K 0.21% 101
2022
Q1
$407K Sell
1,932
-1
-0.1% -$217 0.16% 106
2021
Q4
$464K Buy
+1,933
New +$497K 0.18% 98

Other funds holding BIIB